What does Dokter Galina Khorosheva Endocrinologie do?

Dokter Galina Khorosheva Endocrinologie is a specialist medical practice in Leuven. Private Limited, started on 25 March 2020, 1 establishment.

What is the address of Dokter Galina Khorosheva Endocrinologie?

The registered office of Dokter Galina Khorosheva Endocrinologie is located at Ravenstraat 47, 3000 Leuven.

Is Dokter Galina Khorosheva Endocrinologie still active?

Yes. According to the CBE (2 October 2026) Dokter Galina Khorosheva Endocrinologie is active, legal situation “Normale toestand”, started on 25 March 2020.

Is Dokter Galina Khorosheva Endocrinologie registered on Peppol?

Yes, Dokter Galina Khorosheva Endocrinologie is registered on the Peppol network with ID 0208:0745633555.

What is the enterprise number of Dokter Galina Khorosheva Endocrinologie?

The enterprise number of Dokter Galina Khorosheva Endocrinologie is BE0745633555.

When was Dokter Galina Khorosheva Endocrinologie founded?

Dokter Galina Khorosheva Endocrinologie was founded on 25 March 2020.

Who are the directors of Dokter Galina Khorosheva Endocrinologie?

According to the 2025 annual accounts, the directors of Dokter Galina Khorosheva Endocrinologie are: Galina Khorosheva.

Is Dokter Galina Khorosheva Endocrinologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 March 2020; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Galina Khorosheva Endocrinologie make in 2025?

Dokter Galina Khorosheva Endocrinologie posted a profit after taxes of € 133,267 in financial year 2025.

What is the revenue of Dokter Galina Khorosheva Endocrinologie?

As a small company, Dokter Galina Khorosheva Endocrinologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 175,615.

Dokter Galina Khorosheva Endocrinologie (Private Limited)

Dossier Dokter Galina Khorosheva Endocrinologie, printed on 2 October 2026 from databakkes.be/en/0745633555/dokter-galina-khorosheva-endocrinologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter Galina Khorosheva Endocrinologie from Leuven, company number BE0745633555, closed financial year 2025 with a result of € 133,267 after tax. For that financial year Dokter Galina Khorosheva Endocrinologie recorded a gross margin of € 175,615 and equity of € 138,267. Compared with financial year 2024, the result moved from € 99,323 to € 133,267. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 7, 2026.

What it is worth Growing

€ 138,267

▲ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 133,267

▲ 34% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 133,105

▲ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 99,323 paid out

75 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 269

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 10,119

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 664

▼ 82% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,969

▲ 257% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 58,799 Gross margin 2022: € 58,799 First fiscal year in the series	€ 86,394 Gross margin 2023: € 86,394 ▲ 47% vs 2022 (€ 58,799) Favourable step	€ 129,354 Gross margin 2024: € 129,354 ▲ 50% vs 2023 (€ 86,394) Favourable step	€ 175,615 Gross margin 2025: € 175,615 ▲ 36% vs 2024 (€ 129,354) Favourable step	▲ 36%
Profit after taxes	€ 45,192 Profit after taxes 2022: € 45,192 First fiscal year in the series	€ 67,254 Profit after taxes 2023: € 67,254 ▲ 49% vs 2022 (€ 45,192) Favourable step	€ 99,323 Profit after taxes 2024: € 99,323 ▲ 48% vs 2023 (€ 67,254) Favourable step	€ 133,267 Profit after taxes 2025: € 133,267 ▲ 34% vs 2024 (€ 99,323) Favourable step	▲ 34%
Equity	€ 60,800 Equity 2022: € 60,800 First fiscal year in the series	€ 128,054 Equity 2023: € 128,054 ▲ 111% vs 2022 (€ 60,800) Favourable step	€ 104,323 Equity 2024: € 104,323 ▼ 19% vs 2023 (€ 128,054) Unfavourable step	€ 138,267 Equity 2025: € 138,267 ▲ 33% vs 2024 (€ 104,323) Favourable step	▲ 33%
Total debts	€ 14,337 Total debts 2022: € 14,337 First fiscal year in the series	€ 20,462 Total debts 2023: € 20,462 ▲ 43% vs 2022 (€ 14,337) Unfavourable step	€ 5,350 Total debts 2024: € 5,350 ▼ 74% vs 2023 (€ 20,462) Favourable step	€ 16,883 Total debts 2025: € 16,883 ▲ 216% vs 2024 (€ 5,350) Unfavourable step	▲ 216%
Cash	€ 72,301 Cash 2022: € 72,301 First fiscal year in the series	€ 145,453 Cash 2023: € 145,453 ▲ 101% vs 2022 (€ 72,301) Favourable step	€ 106,853 Cash 2024: € 106,853 ▼ 27% vs 2023 (€ 145,453) Unfavourable step	€ 133,105 Cash 2025: € 133,105 ▲ 25% vs 2024 (€ 106,853) Favourable step	▲ 25%
Retained profit	€ 55,800 Retained profit 2022: € 55,800 First fiscal year in the series	€ 123,054 Retained profit 2023: € 123,054 ▲ 121% vs 2022 (€ 55,800) Favourable step	€ 99,323 Retained profit 2024: € 99,323 ▼ 19% vs 2023 (€ 123,054) Unfavourable step	€ 133,267 Retained profit 2025: € 133,267 ▲ 34% vs 2024 (€ 99,323) Favourable step	▲ 34%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 123,054 Dividend 2024: € 123,054 Unchanged (€ 0) Unchanged	€ 99,323 Dividend 2025: € 99,323 ▼ 19% vs 2024 (€ 123,054) Unchanged	▼ 19%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 10,119 Bank debt 2025: € 10,119 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 75,137 Balance sheet total 2022: € 75,137 First fiscal year in the series	€ 148,516 Balance sheet total 2023: € 148,516 ▲ 98% vs 2022 (€ 75,137) Unchanged	€ 109,673 Balance sheet total 2024: € 109,673 ▼ 26% vs 2023 (€ 148,516) Unchanged	€ 155,150 Balance sheet total 2025: € 155,150 ▲ 41% vs 2024 (€ 109,673) Unchanged	▲ 41%

Key figures of Dokter Galina Khorosheva Endocrinologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dokter Galina Khorosheva Endocrinologie?

What happened at Dokter Galina Khorosheva Endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 7, 2026 New annual accounts for financial year 2025: profit of € 133,267 (▲ 34% vs 2024). Source: NBB ↗
Mar 25, 2020 New establishment in Leuven. KBO
Mar 25, 2020 Start of the company according to the CBE. KBO

In short

From € 45,192 profit in 2022 to € 133,267 profit in 2025.

Paid € 96,977 in corporate taxes since 2022.

Best year ever: 2025, with € 133,267 profit.

Paid out € 222,377 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Galina Khorosheva Endocrinologie? We notify you, reason included.

Follow Dokter Galina Khorosheva Endocrinologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Galina Khorosheva

Dokter Galina Khorosheva Endocrinologie

Behind Dokter Galina Khorosheva Endocrinologie is Galina Khorosheva.

See the full network in the app

Directors

According to the 2025 annual accounts

Galina Khorosheva

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Ravenstraat 47

3000 Leuven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ARTESCO

€ 51,818 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0745.633.555
VAT number: BE 0745.633.555
Registered office: Ravenstraat 47, 3000 Leuven
Names & denominations: Dokter Galina Khorosheva Endocrinologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 March 2020
Peppol: Active · Active since 31 Oct 2023
Contact: [email protected] 0499266821
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗